The Australian government has alleged in federal court filings that 3M possessed internal knowledge for over 50 years that its products posed serious harm to human health, yet failed to disclose or adequately warn consumers and regulators about the risks.
The allegations, contained in exclusive court documents reviewed by the Guardian, claim that 3M held internal company records that explicitly warned about toxic properties in its product lines. This assertion represents a major development in ongoing litigation against the manufacturing conglomerate over the safety of products sold to Australian consumers and businesses.
The timing of this disclosure carries weight. If proven, a half-century knowledge gap between internal awareness and public disclosure would constitute one of the most extensive periods of alleged concealment in recent corporate liability cases. Such prolonged withholding of safety information typically triggers scrutiny under consumer protection laws, trade practices legislation, and product liability statutes.
3M manufactures thousands of products spanning healthcare, industrial, consumer, and safety sectors. The company has faced mounting legal pressure globally over perfluorinated compounds, commonly called PFAS or "forever chemicals," found in firefighting foams, non-stick coatings, and water-resistant treatments. PFAS accumulate in human blood and persist indefinitely in the environment, with research linking exposure to kidney disease, liver damage, thyroid dysfunction, and reproductive harm.
The Australian Federal Court case represents part of a broader litigation wave confronting 3M internationally. In the United States, the company agreed in 2023 to pay $10.3 billion to settle claims related to PFAS contamination in water supplies across multiple states. State attorneys general documented how 3M knew about PFAS persistence and bioaccumulation decades before public acknowledgment of the problem.
Internal corporate documents from 3M obtained during discovery in previous cases revealed that researchers working for the company identified PFAS risks as early as the 1970s. Email chains and laboratory reports showed that toxicologists within 3M communicated concerns about environmental persistence and health effects through internal channels while the company continued marketing products containing these compounds without public warning.
The Australian government's court filing suggests that pattern extends to Australian operations. If the federal government can establish that 3M deliberately concealed known hazards from Australian consumers and authorities, the company could face liability under the Competition and Consumer Act, which prohibits misleading or deceptive conduct in trade or commerce. Australian law also provides grounds for claims that 3M breached a duty to warn about known product defects.
What distinguishes the Australian case is the government's apparent focus on the duration and deliberateness of non-disclosure. Establishing that knowledge existed across five decades creates a narrative of systematic concealment rather than evolving scientific understanding. Regulators and courts increasingly scrutinize whether companies distinguished between genuine scientific uncertainty and deliberate suppression of inconvenient findings.
The filing's implications extend beyond 3M. Australian manufacturers face potential exposure if they similarly possessed internal warnings about product safety while withholding information from the public. The case may establish precedent for how Australian courts evaluate corporate knowledge and the timing of disclosure obligations.
3M has consistently stated that its products comply with regulations in effect at the time of manufacture and sale. The company maintains that PFAS exposure from consumer products poses minimal health risk compared to other environmental sources. However, regulatory understanding of PFAS toxicity has evolved dramatically in recent years, with multiple nations restricting or phasing out certain applications.
The Australian Federal Court will determine whether the government can substantiate its allegations with documentary evidence and expert testimony about 3M's knowledge and decision-making processes during the alleged 50-year period.